Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. - Test2 - elhamkhani - TriplyDB

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

http://www.wikidata.org/entity/Q34660924

about

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia Metabolic profiling of tenacigenin B, tenacissoside H and tenacissoside I using UHPLC-ESI-Orbitrap MS/MS.Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.Regulation of CYP3A genes by glucocorticoids in human lung cells Metabolic considerations of drugs in the treatment of allergic diseases.Flunisolide for the treatment of asthma.Cytochrome P450 interactions and clinical implication in rheumatology.Inhaled corticosteroids and HPA axis suppression: how important is it and how should it be managed?Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.Antiinflammatory Effects of Budesonide in Human Fetal Lung.Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.Predicting anxiety responses to halogenated glucocorticoid drugs using the hexobarbital sleep time test.Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome.Effects of budesonide and surfactant in preterm, fetal sheep.

P2860

Q28080752-73999EFC-FA90-4867-A7D3-E312FE36D0C4 Q28542831-8EB611C4-88E9-4DD6-9FA0-A839DE290307 Q35997231-E7504C94-FCFA-4A43-B374-DCB42CBA3B68 Q36776572-2C9B8D80-3325-4ABB-9F78-AB85DADB9A45 Q37137128-6CA93FA4-A2C6-4D01-9917-1044112F035A Q37406800-3921D5E2-5F1D-4E41-B03E-25AB52CD549E Q38125525-5C31780F-D892-44AA-AAC5-58E9A2708BE5 Q38203322-4F87CED9-C16D-420B-932E-9C55031A1793 Q38219868-50A51235-13DF-4DE5-A57E-9A5E6916B0D6 Q38796254-A9E08CFF-80EF-411D-971F-D5451C66BE6D Q39098740-3C143669-5673-4046-9B12-03E19C841643 Q40489148-A7F4C472-4AF1-45E9-BCA1-76344E996384 Q40505997-4E1153CE-4FC3-4EAA-99AA-76533C8F5F65 Q41624660-88BAC829-1BE6-4111-B6AF-646BFCFE845C Q47430326-0CCC47DF-B8A3-4EBC-8257-BAF2E6048C09 Q49608204-526EDE1B-DFD8-41A3-96B5-E33BF5572075 Q50062062-0B5908C9-82A1-41D4-9EF0-E47BDBFB527F Q52718375-D7B369C2-03BA-4B0D-83BC-54D33B87AC48

P2860

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

http://www.wikidata.org/entity/Q34660924

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@ast

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@en

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@nl

type

label

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@ast

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@en

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@nl

prefLabel

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@ast

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@en

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@nl

P1433

Q34660924-C3310D3D-36A1-4E1B-AFE6-5A6E88326910

P1476

Q34660924-C365B83C-55DE-44B7-88C4-B3D1A5571AB0

P2093

Q34660924-2A5DDC8B-DC2D-46DD-8C45-6D2BD3886116

Q34660924-6AF67ED1-7365-4A9E-8EB1-B26F756CE102

Q34660924-6B6E7E72-92C5-4B3D-8944-61A3DC8CAB96

Q34660924-A81D916F-050B-473C-91E5-DFFA61792543

Q34660924-B41C2D54-8FE1-46DF-97C1-8241B96D0012

Q34660924-C63C902D-D95F-4E99-99E4-FAA1DDA513CD

Q34660924-E0E62169-832C-4654-8AD8-6A1BEABCAAC2

Q34660924-E31C57B9-AF2D-47F2-A90A-DF663F317871

P2860

Q34660924-00F9BC5C-3811-4D97-9FAA-FA85A8D2A77D

Q34660924-0EE169E3-CE70-4C71-87A0-D0ED8DF7F1D5

Q34660924-109B1E35-BFF7-4C2A-AA84-639E0CB06700

Q34660924-267CEF43-FAE1-4704-A6E4-FFBC8202993D

Q34660924-2EDA9FAF-52EA-420C-B4AF-3D7B8E8E6035

Q34660924-36A0289F-E22D-46F3-8CB5-2FC0B8523D40

Q34660924-3863424F-28EE-41BF-A500-ED77D28245B7

Q34660924-58B774A7-F2F2-4ABD-89F8-BCE381B0BEB5

Q34660924-61C06797-665E-4FA1-B928-DE3F2BBEBE90

Q34660924-655155C8-14B7-4A1D-AAB2-0C682547F25E

P304

Q34660924-E54CA271-ABCD-42C8-A23F-DAFEBD3F163B

P31

Q34660924-671311D9-E34E-4781-A46B-1CB6972718AF

P356

Q34660924-0B741F7F-E8DC-421A-B94C-87A6FC79C28F

P433

Q34660924-2E8510B0-D9FE-463C-9E73-3E3B4D26D925

P478

Q34660924-788A218A-9D5C-4F54-8C1F-62020429761D

P577

Q34660924-71D49F31-600C-4B16-8C2B-0C45DD845E44

P5875

Q34660924-0834501A-736D-4245-8492-ECAD73F899A7

P698

Q34660924-565B7E2A-E044-4182-A282-C976D4B66AE5

P932

Q34660924-6CCD615E-C1F5-4193-893B-C599EE1B3BB5

P356

P1433

Drug Metabolism and Disposition

P1476

Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.

@en

P2093

Chad D Moore

http://www.w3.org/2001/XMLSchema#string

Christopher A Reilly

http://www.w3.org/2001/XMLSchema#string

Christopher R Orton

http://www.w3.org/2001/XMLSchema#string

Garold S Yost

http://www.w3.org/2001/XMLSchema#string

Jessica K Roberts

http://www.w3.org/2001/XMLSchema#string

Robert M Ward

http://www.w3.org/2001/XMLSchema#string

Takahiro Murai

http://www.w3.org/2001/XMLSchema#string

Trevor P Fidler

http://www.w3.org/2001/XMLSchema#string

P2860

Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver

cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450

The importance of genetic influences in asthma.

Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.

The inhaled glucocorticoid fluticasone propionate efficiently inactivates cytochrome P450 3A5, a predominant lung P450 enzyme.

Update on glucocorticoid action and resistance.

Biochemical basis of asthma therapy.

Pharmacokinetic optimisation of asthma treatment.

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.

Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells.

P304

379-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.112.046318

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233396071

http://www.w3.org/2001/XMLSchema#string

P698

23143891

http://www.w3.org/2001/XMLSchema#string

P932

3558858

http://www.w3.org/2001/XMLSchema#string